- Home
- MIST vs EDF Comparison
MIST vs EDF Comparison
Compare MIST & EDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIST | EDF |
|---|---|---|
| Founded | 2003 | 2010 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 153.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MIST | EDF |
|---|---|---|
| Price | $1.70 | $5.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 160.6K |
| Earning Date | 03-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.14% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $3.51 |
| 52 Week High | $3.06 | $5.50 |
Technical Indicators
Market Signals| Indicator | MIST | EDF |
|---|---|---|
| Relative Strength Index (RSI) | 34.51 | 61.60 |
| Support Level | $1.70 | $5.08 |
| Resistance Level | $1.89 | $5.04 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 2.86 | 75.51 |
Price Performance
Historical ComparisonAbout MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About EDF Virtus Stone Harbor Emerging Markets Income Fund of Beneficial Interest
Virtus Stone Harbor Emerging Markets Income Fund is a closed-end management investment company. Its investment objective is to maximize total return, which consists of income from its investments and capital appreciation. The Fund normally will invest at least 80% of its net assets (plus any borrowings for investment purposes) in emerging markets securities.